-
Mashup Score: 1
DESTIN, Fla. — Understanding when to switch from one class of drugs to another is critical to maintaining bone health and preventing fractures in osteoporosis, according to data presented at the Congress of Clinical Rheumatology East.“It is quite clear that the sequence in which drugs are given has important clinical consequences,” Michael R. McClung, MD, of Australian Catholic
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1
DESTIN, Fla. — Understanding when to switch from one class of drugs to another is critical to maintaining bone health and preventing fractures in osteoporosis, according to data presented at the Congress of Clinical Rheumatology East.“It is quite clear that the sequence in which drugs are given has important clinical consequences,” Michael R. McClung, MD, of Australian Catholic
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Understanding when to switch from one class of drugs to another is critical to maintaining bone health and preventing #fractures in #osteoporosis #CCR2022 https://t.co/WFsNsBMxlJ
-
Understanding when to switch from one class of drugs to another is critical to maintaining bone health and preventing #fractures in #osteoporosis #CCR2022 https://t.co/4xzNyQgBth
-
-
Mashup Score: 1
DESTIN, Fla. — Early treatment can provide patients with axial spondyloarthritis a better opportunity to achieve drug-free remission and slow disease progression, according to a speaker at the Congress of Clinical Rheumatology East 2022.Specifically, Janus kinase inhibitors such as tofacitinib (Xeljanz, Pfizer), upadacitinib (Rinvoq, AbbVie) and filgotinib (Gilead Sciences/ Galapagos NV)
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Early treatment can provide patients with axial #spondyloarthritis a better opportunity to achieve drug-free remission and slow disease progression #CCR2022 https://t.co/fIHvZkTypI
-
-
Mashup Score: 0‘Predicting the future’: Emerging technology may help choose right drug at the right time - 2 year(s) ago
Remote patient monitoring using novel technology may make it possible for rheumatologists to choose the “right drug right out of the gate,” according to data presented at the Congress of Clinical Rheumatology East.Jeffrey R. Curtis, MD, of the University of Alabama at Birmingham, noted that a wide array of technological advances, from clinical informatics to drug selection using
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Remote patient monitoring using novel technology may make it possible for rheumatologists to choose the “right drug right out of the gate" #CCR2022 https://t.co/iUAdHLbJN0
-
-
Mashup Score: 0
DESTIN, Fla. — Hydroxychloroquine may no longer be the optimal treatment option for systemic dermatomyositis, according to data presented at the Congress of Clinical Rheumatology East. In her presentation, Avery H. LaChance, MD, MPH, director of the Connective Tissue Diseases Clinic at Brigham and Women’s Hospital, and assistant professor of dermatology at Harvard Medical School, said
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
#Hydroxychloroquine may no longer be the optimal treatment option for systemic dermatomyositis #RheumTwitter #CCR2022 https://t.co/HmTVCnv4tw
-
-
Mashup Score: 1
DESTIN, Fla. — Systemic lupus erythematosus may benefit from being redefined and further subdivided, depending on the autoantibody profile of the patient, according to a speaker at the Congress of Clinical Rheumatology East 2022.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
#SLE may benefit from being redefined and further subdivided, depending on the autoantibody profile of the patient #RheumTwitter #CCR2022 #CCR22 https://t.co/C66S0Enaco
-
-
Mashup Score: 0
Although not currently curable, the symptoms of Sjögren’s syndrome, like dry eyes and dry mouth, can be effectively managed using a variety of therapies, said a speaker said at the Congress of Clinical Rheumatology East 2022 meeting.“There are no curative therapies, but we certainly have the tools to palliate these symptoms and prevent complications,” Frederick B. Vivino, MD,
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Although not currently curable, the symptoms of #Sjögrens syndrome, like #dryeye and dry mouth, can be effectively managed using a variety of therapies #RheumTwitter #CCR2022 #CCR22 @Healio_OSN https://t.co/o4KOCqp0Qa
-
-
Mashup Score: 0
Myriad symptoms and three different sets of classification criteria make Sjögren’s syndrome a challenging diagnosis, according to a presenter at the Congress of Clinical Rheumatology East.“Sjögren’s is an oft-neglected topic in rheumatology,” Fredrick B. Vivino, MD, MS, of Penn Presbyterian Medical Center, in Philadelphia, said in his presentation.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
“Sjögren’s is an oft-neglected topic in rheumatology,” Fredrick B. Vivino, MD, MS, said at #CCR2022 #RheumTwitter https://t.co/QPr19g20nD
-
-
Mashup Score: 2VIDEO: Immunocompromised care in COVID-19 to challenge physicians ‘for rest of our lives’ - 2 year(s) ago
DESTIN, Fla. — All patients who are immunocompromised should be educated about how to recognize COVID-19 infection early and when to report to the emergency room, according to Leonard H. Calabrese, DO, at the Congress of Clinical Rheumatology East.These patients also require access to home testing, as many of the available COVID-19 therapies, including antivirals and monoclonal antibodies,
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
All patients who are immunocompromised should be educated about how to recognize COVID-19 infection early and when to report to the emergency room, according to @LCalabreseDO #CCR2022 #RheumTwitter #COVID19 https://t.co/0olrXOP9Fz
-
-
Mashup Score: 0
An ever-increasing array of treatment options is allowing rheumatologists to target specific disease domains in their patients with psoriatic arthritis, according to a speaker at the Congress of Clinical Rheumatology East.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
An ever-increasing array of treatment options is allowing #rheumatologists to target specific disease domains in their patients with psoriatic #arthritis #CCR2022 https://t.co/mcm7RNisd1
-
“Optimal management must be individualized but will involve sequential use of different classes of osteoporosis drugs,” Michael R. McClung, MD, told #CCR2022 attendees #RheumTwitter #Osteoporosis https://t.co/4xzNyQgBth